ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1947

Do Changes in Pain Sensitization and Depressive Symptoms Mediate the Effect of Extreme Weight Loss on Knee Pain Improvement?

S. Reza Jafarzadeh1, Tuhina Neogi1, Joshua J. Stefanik2, Margaret M. Clancy1, Jing-Sheng Li3 and David T. Felson1, 1Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, 2Department of Physical Therapy, University of Delaware, Newark, DE, 3College of Health and Rehabilitation Sciences: Sargent College, Boston University, Boston, MA

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Knee, Mediation, Osteoarthritis, pain and weight loss

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: 4M117 ARHP Abstract: Pain, Anxiety, & Depression–ARHP I (1946–1951)

Session Type: ARHP Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: We previously showed that the one-year effects of weight loss on knee pain reduction were not mediated by changes in structural features of osteoarthritis such as bone marrow lesions and synovitis. We aimed to assess whether the knee pain improvement in these persons could be explained by changes in pain sensitization or depressive symptoms.

Methods: Morbidly obese persons with body mass index ≥ 35 kg/m2, from the Nutrition and Weight Management Center who had knee pain on most days of the past month were eligible. Patients were evaluated at baseline, before bariatric surgery or medical weight management, and at one-year. Measurements from both visits included WOMAC pain subscale score, pressure pain threshold (PPT) obtained at index patella and right wrist as an indication of peripheral/central and central sensitization, respectively, and depressive symptoms derived from the Center for Epidemiologic Studies Depression (CES-D) scale. Improvement in pain beyond a minimal clinically important difference (MCID) of 18% (i.e., ≥18% reduction) in WOMAC score was defined as the outcome. We defined the exposure as weight loss of ≥20% and focused on potential mediators defined as the change in patella and wrist PPT and CES-D score from baseline to follow-up. For mediation analysis, we fit natural effects models to quantify the magnitude of weight loss effect on pain improvement through a mediator-specific causal pathway; this is the mediating or indirect effect, and the remaining direct effect that is independent of the mediator-specific pathway (Figure 1).

Results: Of 75 study participants, 53% (40/75) lost ≥20% body weight by one-year follow-up. Of these 40, 39 (98%) underwent bariatric surgery compared to 23% (8/35) of participants who experienced <20% weight loss. Pain improvement at MCID level or beyond was observed in 75% (30/40) of those with ≥20% weight loss, compared to 34% (12/35) who lost <20% bodyweight. Natural indirect effect estimates suggested increased odds of pain improvement through changes in patella PPT (odds ratio [OR] = 1.62, 95% CI: 0.89, 2.75), wrist PPT (OR = 1.15, 95% CI: 0.77, 1.77), and CES-D score (OR = 1.22, 95% CI: 0.77, 1.87). However, the bootstrap-based confidence intervals around our reported effect sizes slightly overlapped the null value of 1.

Conclusion: Weight loss-induced knee pain improvement is partially attributable to reduced pain sensitization and to a lesser extent improvement in depressive symptoms.

Figure 1. Directed acyclic graph

Figure 2. Baseline and follow-up values for PPT and CES-D.


Disclosure: S. R. Jafarzadeh, None; T. Neogi, None; J. J. Stefanik, None; M. M. Clancy, None; J. S. Li, None; D. T. Felson, None.

To cite this abstract in AMA style:

Jafarzadeh SR, Neogi T, Stefanik JJ, Clancy MM, Li JS, Felson DT. Do Changes in Pain Sensitization and Depressive Symptoms Mediate the Effect of Extreme Weight Loss on Knee Pain Improvement? [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/do-changes-in-pain-sensitization-and-depressive-symptoms-mediate-the-effect-of-extreme-weight-loss-on-knee-pain-improvement/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/do-changes-in-pain-sensitization-and-depressive-symptoms-mediate-the-effect-of-extreme-weight-loss-on-knee-pain-improvement/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology